![Eris Lifesciences Limited logo](/logos/ERIS.NS.webp)
Eris Lifesciences Limited
NSE:ERIS.NS
Overview | Financials
Company Name | Eris Lifesciences Limited |
Symbol | ERIS.NS |
Currency | INR |
Price | 1,448.45 |
Market Cap | 197,106,524,450 |
Dividend Yield | 0% |
52-week-range | 792.35 - 1,522.05 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Amit Indubhushan Bakshi |
Website | https://www.eris.co.in |
An error occurred while fetching data.
About Eris Lifesciences Limited
Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD